Scarica l'app Stockscreener
0.581
12.24%
-0.081
Dopo l'orario di chiusura:
.58
-0.001
-0.17%
Precedente Chiudi:
$0.662
Aprire:
$0.6708
Volume 24 ore:
991.48K
Relative Volume:
0.58
Capitalizzazione di mercato:
$73.31M
Reddito:
$4.75M
Utile/perdita netta:
$-7.83M
Rapporto P/E:
2.6688
EPS:
0.2177
Flusso di cassa netto:
$-7.24M
1 W Prestazione:
-22.72%
1M Prestazione:
-95.68%
6M Prestazione:
-0.65%
1 anno Prestazione:
-10.62%
Intervallo 1D:
$0.5806
$0.7199
Intervallo di 1 settimana:
$0.5806
$0.95
Portata 52W:
$0.46
$19.95
Novabay Pharmaceuticals Inc Stock (NBY) Company Profile
Nome
Novabay Pharmaceuticals Inc
Settore
Industria
Telefono
510-899-8800
Indirizzo
2000 Powell Street, Suite 1150, Emeryville, CA
Compare NBY vs VRTX, REGN, ARGX, ALNY, ONC
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
NBY
Novabay Pharmaceuticals Inc
|
0.581 | 83.53M | 4.75M | -7.83M | -7.24M | 0.2177 |
|
VRTX
Vertex Pharmaceuticals Inc
|
465.02 | 117.03B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
783.65 | 82.35B | 14.34B | 4.50B | 3.77B | 41.56 |
|
ARGX
Argen X Se Adr
|
833.54 | 51.64B | 3.06B | 1.28B | 447.35M | 19.67 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
308.48 | 42.58B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ONC
Beone Medicines Ltd Adr
|
346.42 | 38.87B | 4.98B | 69.60M | 525.67M | 0.5198 |
Novabay Pharmaceuticals Inc Stock (NBY) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2019-09-18 | Iniziato | Ladenburg Thalmann | Buy |
| 2018-07-06 | Reiterato | H.C. Wainwright | Buy |
| 2017-11-15 | Reiterato | Laidlaw | Buy |
| 2017-06-05 | Iniziato | ROTH Capital | Buy |
| 2017-03-27 | Iniziato | Laidlaw | Buy |
| 2017-02-06 | Iniziato | Rodman & Renshaw | Buy |
| 2016-03-07 | Downgrade | Maxim Group | Buy → Hold |
| 2015-12-14 | Reiterato | Maxim Group | Buy |
| 2015-04-30 | Ripresa | Maxim Group | Buy |
| 2013-03-06 | Iniziato | Ascendiant Capital Markets | Strong Buy |
| 2008-01-03 | Iniziato | Dawson James | Speculative Buy |
Mostra tutto
Novabay Pharmaceuticals Inc Borsa (NBY) Ultime notizie
NovaBay Pharma Announces 1-for-5 Reverse Stock Split - TipRanks
Reverse split shrinks NovaBay (NYSE: NBY) share count fivefold - Stock Titan
NovaBay Pharmaceuticals Announces 1-for-5 Reverse Stock Split - TradingView
Aug Volume: Should you avoid NovaBay Pharmaceuticals Inc stock right now2025 Market WrapUp & Free Expert Verified Stock Movement Alerts - baoquankhu1.vn
Quarterly Recap: Will NovaBay Pharmaceuticals Inc stock hit new highs in YEARMarket Risk Summary & Real-Time Stock Price Movement Reports - baoquankhu1.vn
Massive warrant deals and share increase at NovaBay (NYSE: NBY) head to vote - Stock Titan
Profit Recap: Is NovaBay Pharmaceuticals Inc stock a top performer YTDDip Buying & Expert Curated Trade Setups - baoquankhu1.vn
Pullback Watch: Will Arko Corp benefit from government policyMarket Weekly Review & Capital Protection Trading Alerts - baoquankhu1.vn
NovaBay Pharmaceuticals appoints new auditor and announces special shareholder meeting - Investing.com India
NovaBay Pharma Schedules Special Shareholder Meeting on Warrants - TipRanks
Is NovaBay Pharmaceuticals Inc. stock a top performer YTDJuly 2025 Breakouts & Fast Moving Stock Trade Plans - mfd.ru
NovaBay Pharmaceuticals (NYSEAMERICAN:NBY) Stock Passes Below 50 Day Moving AverageHere's Why - MarketBeat
Auditor change as NovaBay (NBY) seeks approval to dissolve - Stock Titan
NovaBay Pharmaceuticals (NYSEAMERICAN:NBY) Stock Price Down 14.3%Should You Sell? - MarketBeat
NovaBay Pharmaceuticals enters $100 million at-the-market sales agreement By Investing.com - Investing.com Canada
NovaBay Pharmaceuticals (NYSEAMERICAN:NBY) Shares Gap DownShould You Sell? - MarketBeat
NovaBay falls on deal for $100M stock (update) (NBY:NYSE) - Seeking Alpha
NovaBay Pharmaceuticals (NBY) Announces $100M Stock Sale Agreement with Virtu Americas - intellectia.ai
Aug PostEarnings: What is NovaBay Pharmaceuticals Incs 5 year growth outlookJuly 2025 Chart Watch & Fast Gaining Stock Reports - baoquankhu1.vn
NovaBay Pharmaceuticals stock falls after $100 million ATM offering By Investing.com - Investing.com Canada
NovaBay Pharma Establishes $100 Million ATM Equity Program - TipRanks
NovaBay Pharmaceuticals enters $100 million at-the-market sales agreement - Investing.com
NovaBay Pharmaceuticals Signs ATM Sales Agreement With Virtu Americas - TradingView
Performance Recap: Does NovaBay Pharmaceuticals Inc have a sustainable dividend2025 Investor Takeaways & Daily Profit Maximizing Tips - baoquankhu1.vn
Assessing NovaBay Pharmaceuticals (NBY) Valuation After Digital Asset Financing And SKY Token Treasury Shift - Sahm
Is NovaBay Pharmaceuticals Inc stock heavily shortedWeekly Trend Summary & Risk Adjusted Buy and Sell Alerts - baoquankhu1.vn
Jobs Data: What is NovaBay Pharmaceuticals Incs 5 year growth outlookWeekly Investment Report & High Accuracy Trade Signal Alerts - baoquankhu1.vn
NovaBay Pharma Secures Crypto-Focused Financing, Shifts Strategy - The Globe and Mail
NovaBay Pharmaceuticals announces $134 million private placement of pre-funded warrants By Investing.com - Investing.com Nigeria
NovaBay Pharmaceuticals announces $134 million private placement of pre-funded warrants - Investing.com Nigeria
NovaBay Pharmaceuticals Signs Multiple Material Agreements - TradingView
NovaBay (NYSE: NBY) sells pre-funded warrants for $134M financing - Stock Titan
NovaBay Pharmaceuticals (NYSEAMERICAN:NBY) Trading Up 13.2%Time to Buy? - MarketBeat
Decliners Report: Is QDWN subject to activist investor interestPortfolio Gains Report & AI Enhanced Trading Alerts - baoquankhu1.vn
NovaBay Pharmaceuticals (NYSEAMERICAN:NBY) Shares Down 8.3%Should You Sell? - MarketBeat
NovaBay Pharmaceuticals, Inc. (NYSEAMERICAN:NBY) Sees Large Increase in Short Interest - MarketBeat
Buybacks Report: Can NovaBay Pharmaceuticals Inc stock sustain market leadership2025 Technical Overview & Community Verified Watchlist Alerts - Bộ Nội Vụ
Hedge Fund Bets: How supply chain issues affect NovaBay Pharmaceuticals Inc. stockMarket Growth Review & Stock Timing and Entry Methods - Bộ Nội Vụ
NovaBay: 'Hold' Rating As New M&A Direction Could Evolve But With Risks (NYSE:NBY) - Seeking Alpha
Why NovaBay Pharmaceuticals (NBY) Is Up 99.3% After Pivoting From Liquidation To Restructuring And Asset Sales - Sahm
CEO Moves: Is NovaBay Pharmaceuticals Inc subject to activist investor interestChart Signals & Verified Swing Trading Watchlists - baoquankhu1.vn
NovaBay Pharmaceuticals (NBY) Stock: Why Shares Exploded 103% on Friday - Blockonomi
NovaBay Pharmaceuticals (NBY) stock slides premarket after 102% surge — dilution risk back on radar - TechStock²
NovaBay Pharmaceuticals (NBY) Stock: Why Shares Just Doubled in One Day - CoinCentral
NovaBay stock more than doubles on thin float — what to watch for NBY when markets reopen - TechStock²
NovaBay Pharmaceuticals stock jumps 102% — what to watch for NBY before Monday - TechStock²
Assessing NovaBay Pharmaceuticals’ (NBY) Valuation After A Sharp Short Term Share Price Surge - Yahoo Finance
NovaBay Pharmaceuticals stock doubles as NBY volatility flares again — what to watch next - TechStock²
Published on: 2026-01-11 02:58:32 - ulpravda.ru
Novabay Pharmaceuticals stock hits 52-week high at 11.49 USD By Investing.com - Investing.com Nigeria
Novabay Pharmaceuticals Inc Azioni (NBY) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
1.24%
0.19%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):